TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/9/23 18:02 | 5/5/23 | DICE | Dice Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Scheller Richard H | CA | D | S | -3,238 | 38.51 | 0 | -84 | -91 | 8 | D | |||||||||||||||
2/21/23 20:21 | 2/16/23 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Scheller Richard H | CA | D | M.d | 0 | 0.00 | 0 | 3 | 6 | 54 | D | |||||||||||||||
11/18/22 18:38 | 11/16/22 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Scheller Richard H | CA | D | M.d | 0 | 0.00 | 0 | 3 | 7 | 52 | D | |||||||||||||||
11/14/22 16:38 | 11/11/22 | ME | 23Andme Holding Co. | Health | Drug | Pharmaceutical Preparations | Scheller Richard H | CA | D | S | -60 | 3.24 | 0 | -18 | -20 | 72 | D | ||||||||||||||||
8/18/22 18:35 | 8/16/22 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Scheller Richard H | CA | D | M.d | 0 | 0.00 | 0 | 3 | 7 | 50 | D | |||||||||||||||
5/18/22 16:09 | 5/16/22 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Scheller Richard H | CA | D | M.d | 0 | 0.00 | 0 | 3 | 7 | 48 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |